GOLD Learning Speakers

United Kingdom

Wendy Jones, PhD MRPharmS

  • Speaker Type: GOLD Midwifery 2017, Optimizing Milk Production Lecture Pack 2018, GOLD Learning Day 2020
  • Country: United Kingdom
Biography:

In her employed life Wendy was a community pharmacist and also worked in doctor surgeries supporting cost effective, evidence-based prescribing.

Wendy left paid work to concentrate on writing Breastfeeding and Medication (Routledge 2nd edition 2018), developing information and training material on drugs in breastmilk as well as setting up her own website www.breastfeeding-and-medication. She has also published Breastfeeding for Dads and Grandmas (Praeclarus Press) and Why Mothers Medication Matters (Pinter and Martin). She is also co editor of a book to be published January 2020 called A guide to breastfeeding for medical professionals (Routledge).

Wendy is known for her work on providing a service on the compatibility of drugs in breastmilk and has been a breastfeeding peer supporter for 30 years. She is passionate that breastfeeding should be valued by all and that medication should not be a barrier. She has 3 daughters and 5 grandchildren. All her family seem as passionate about breastfeeding as she is and currently all 3 of her daughters are breastfeeding.

She was awarded a Points of Light award by the Prime Minister in 2018 and nominated for an MBE in the New Year's Honours List 2018 for services to mothers and babies. She received her award at Windsor Castle in May 2019 from Her Majesty the Queen.

CE Library Presentation(s) Available Online:
Watch Today!
View Lecture
Note: Currently only available through a bundled series of lectures
Breastfeeding And Medication: How To Make An Evidence Based Decision On Safety
In the past 21 years of providing support to breastfeeding mothers requiring medication I have found that many women are given information which isn’t based on evidence. Sharing decision-making is about being honest about the limits of knowledge and not just about healthcare professionals avoiding risk. To make an informed decision mothers need an unbiased explanation of options with benefits and risks about what is known about the medicine and its passage into breastmilk. Interrupting breastfeeding to take medication also has risks and we cannot ignore the difficulties that pumping and dumping, produce for the mother. I aim to provide the tools to evaluate the risks and benefits of prescribing and taking medication during breastfeeding and to discuss some of the more commonly encountered conditions where treatment is necessary to maintain a mother if full health to nurture and care for her baby.
Accreditation, Main Category, Product Type
Presentations: 13  |  Hours / CE Credits: 13.5  |  Viewing Time: 8 Weeks
Hours / CE Credits: 1 (details)  |  Categories: Midwifery
Watch Today!
View Lecture
Note: Currently only available through a bundled series of lectures
Galactogogues and Breastfeeding
We know that the most common reason mums stop breastfeeding before they would otherwise choose is because they believe they don’t have enough breastmilk. In many cultures there a herbal remedies to increase milk supply. We have medicinal options available as well. What is the research behind the “magic wands”? Can any products cause harm rather than benefit? When should they be used and when is skilled breastfeeding support more important? Why is some populations is poor milk supply never a concern? Who is responsible for the perceived need to increase milk supply?
Accreditation, Main Category
Presentations: 6  |  Hours / CE Credits: 6  |  Viewing Time: 4 Weeks
Hours / CE Credits: 1 (details)  |  Categories: Breastfeeding and Lactation
Watch Today!
View Lecture
Note: Currently only available through a bundled series of lectures
Pharmacokinetics and Clinical Implications of Drugs in Human Milk: The Substance-Exposed Infant
We are aware that an increasing number of babies are exposed to opiates, to methadone, to cannabis and cocaine through maternal breastmilk. In this presentation I will discuss the pharmacokinetics of the medications and how this impact on the clinical care of the babies both immediately after delivery and later on. We need mothers to be open and honest about any drugs which they have taken in order that we may care for the baby appropriately if it is exhibiting clinical symptoms. This impacts on safeguarding issues but our aim should be to help the mother consider the impact on her baby using evidence-based information and to maintain breastfeeding appropriately. What are the long- and short-term implications of exposure for mother and baby? Is there sufficient research? As always, more questions than answers.
Presentations: 3  |  Hours / CE Credits: 3  |  Viewing Time: 6 Weeks
Hours / CE Credits: 1 (details)  |  Categories: